The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.

TitleOral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.
Publication TypeJournal Article
Year of Publication2013
AuthorsNicolatou-Galitis, O., Nikolaidi A., Athanassiadis I., Papadopoulou E., & Sonis S.
JournalOral Surg Oral Med Oral Pathol Oral Radiol
Volume116
Issue2
Paginatione110-6
Date Published2013 Aug
ISSN2212-4411
KeywordsAged, Androstadienes, Anti-Inflammatory Agents, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Carcinoma, Dexamethasone, Everolimus, Female, Follow-Up Studies, Glucocorticoids, Humans, Middle Aged, Oral Ulcer, Prospective Studies, Recurrence, Sirolimus, Stomatitis, Stomatitis, Aphthous, TOR Serine-Threonine Kinases, Treatment Outcome
Abstract

OBJECTIVE: We report the clinical features and management outcomes in 7 patients with everolimus-related stomatitis.STUDY DESIGN: Fifteen women with hormone-receptor-positive advanced breast cancer receiving everolimus combined with exemestane were prospectively evaluated to assess the development of stomatitis. Oral ulcers were diagnosed based on established criteria.RESULTS: Seven patients developed stomatitis (46.6%). All patients were treated with topical dexamethasone solution, while everolimus was temporarily discontinued in 4 patients. Stomatitis resolved within 1-2 weeks. Two of the 4 patients, who had interrupted everolimus, developed recurrent stomatitis following drug resume and everolimus was again discontinued and restarted after 2 weeks. To date, 5 patients receive everolimus in full dose. The 2 patients, who developed recurrent stomatitis, received a reduced dose.CONCLUSIONS: Everolimus-related oral ulcers were frequent and led to dose modifications. Controlled trials, endorsing a consensus in terminology, are needed to evaluate measures on prevention and management of this unique toxicity.

DOI10.1016/j.oooo.2013.02.022
Alternate JournalOral Surg Oral Med Oral Pathol Oral Radiol
PubMed ID23643584

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.